Artificial Intelligence In Genomics Market

7500+ companies worldwide approach us every year for their revenue growth inititatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Artificial Intelligence In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research)-Global Forecasts to 2025

FREE BROCHURE FREE SAMPLE REPORT

Report Code: HIT 7852 Mar, 2021, by marketsandmarkets.com

[154 Pages Report] The global AI in genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025. The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.

Artificial Intelligence In Genomics Market

To know about the assumptions considered for the study, download the pdf brochure

Covid-19 Impact on the Global Ai in Genomics Market

The COVID-19 pandemic has served as an accelerator for AI technology and made end users globally more comfortable leveraging these healthcare tools. The adoption of AI in genomic sequences for diagnostics and drug development is expected to gain momentum during and after the COVID-19 pandemic AI IN GENOMICS mARKET dynamics

Driver: Need to control the time and cost of drug discovery and development

Drug discovery is a very costly and lengthy process, owing to which there is a need for alternative tools in discovering new drugs. Drug discovery and development is commonly conducted through in vivo and in vitro methods, which are very costly and time-consuming.

Restraint : Lack of skilled AI workforce and ambiguous regulatory guidelinesFor medical software Healthcare Fraud

An AI is a complex system; to develop, manage, and implement AI systems, companies require a workforce with certain skill sets. For instance, personnel dealing with AI systems should be aware of cognitive computing, ML and machine intelligence, deep learning, and image recognition. Integrating AI solutionsinto existing systems is also a challenging task requiring extensive data processing to replicate humanbrain behavior. Even a minor error can result in system failure or adversely affect the desired result.

Challenge: Laack of curated genomics data

Data is a vital source to train and develop a complete and robust AI system. Earlier, datasets were mostlystructured and entered manually. However, the growing digital footprint and technology adoption, such as IoT in healthcare and life science, has resulted in large data volumes that are unstructured (and in theform of text, voice, or images)

Opportunity: focus on developing human-aware AI systems

The aim of developing AI technologies was to make them human-aware or capable of human thinking patterns. However, creating interactive and scalable machines remains a challenge for the developers of AI machines.

Pharmaceutical & biotechnology companies accounted for the largest market share in 2019

Based on the end user, the AI in genomics market is broadly segmented into pharmaceutical biotechnology companies; healthcare providers; research centers, academic institutes, & governmentorganizations; and other end users. Pharmaceutical & biotechnology companies accounted for the largestshare of the end-user market in 2019. Market growth can be attributed to the rising demand for solutions to cut the time and costs of drug development..

North America accounted for the largest share of the global AI in genomics market in 2019

In 2019, North America accounted for the largest share of the AI in genomics market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US.

Artificial Intelligence In Genomics Market by Region

Some of the key players include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US).

Get online access to the report on the World's First Market Intelligence Cloud
Easy to Download Historical Data & Forecast Numbers
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Request Sample
Click on image to enlarge

Scope of the Report

Report Metric	Details
Market Size Available for Years	2018�2025
Base Year Considered	2019
Forecast Period	2020�2025
Forecast Units	Value (USD)
Segments Covered	Offering, Technology, Functionality, Application, End User, and Region
Geographies Covered	North America (US, and Canada), Europe (Germany, France, UK, and the RoE), Asia Pacific and Rest of the World
Companies Covered	IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US)..

This research report categorizes the AI in genomics market into the following segments:

AI in genomics Market, by Offering

Software
Services

AI in genomics Market, by Technology

Machine Learning
- Deep Learning
- Supervised Learning
- Reinforcement Learning
- Unsupervised Learning
- Other Machine LearningnTechnologies
Other Technologies

AI in genomics Market, by Functionality

Genome Sequencing
Gene Editing
Clinical Workflows
Predictive Genetic Testing & Preventive Medicine

AI in genomics Market, by Application

Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & animal Research
Other Applications

AI in genomics Market, by end user

Pharmaceutical & Biotech Companies
Healthcare Providers
Research Centers, Academic Institutes, &
Government Organizations
Other End Users

AI in genomics Market, by Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Rest of Europe
Asia Pacific
Rest of the World

Recent Developments:

In February 2020, IBM Watson Health signed partnership with Broad Institute of MIT and Harvard (US). An extended partnership will allow the Broad Institute to analyze and explore genomics data to understand intrinsic susceptibility.
In October 2020, NVIDIA announced a partnership with global healthcare company GSK and its AI group. GSK�s new hub in London is expected to support its UK based team and scientists from NVIDIA to enhance drug and vaccine discovery using NVIDIA platforms..

Frequently Asked Questions (FAQ):

How big is the Artificial Intelligence In Genomics Market?

Artificial Intelligence In Genomics Market worth $1,671 million by 2025.

What is the growth rate of Artificial Intelligence In Genomics Market?

Artificial Intelligence In Genomics Market grows at a CAGR of 52.7% during the forecast period.

What is the projected market of the global AI in genomics market in 2025?

The projected market of the global AI in genomics market is expected to be 1,671 million in 2025.

Who are the leading players in the AI in genomics market?

Some of the leading players in the AI in genomics market include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US).

Who are the major end-users of the AI in genomics market?

The end user of the AI in genomics market includes pharmaceutical & biotechnology companies; healthcare providers; research centers, academic institutes, & government organizations; and other end users. Pharmaceutical & biotechnology companies is the largest end-users in the AI in genomics market.

What are the major offering in the AI in genomics market?

Based on the offering, the AI in genomics market is segmented into software and services. The software segment accounted for the largest share of the global AI in genomics market in 2019.

What are the major technology in the AI in genomics market?

Based on the technology, the AI in genomics market is segmented into machine learning and other technologies. The machine learning segment accounted for the largest share of the global AI in genomics market in 2019.

What are the major functionality in the AI in genomics market?

Based on the functionality, the AI in genomics market is segmented into Genome Sequencing, Gene Editing, Clinical Workflows, and Predictive Genetic Testing & Preventive Medicine. The Genome Sequencing segment accounted for the largest share of the global AI in genomics market in 2019.

What are the major application in the AI in genomics market?

Based on the application, the AI in genomics market is segmented into Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, and Other Applications. The diagnostics segment accounted for the largest share of the global AI in genomics market in 2019.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 23)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           FIGURE 1 ARTIFICIAL INTELLIGENCE IN GENOMICS: MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 27)
    2.1 RESEARCH DATA
           FIGURE 2 RESEARCH DESIGN
    2.2 SECONDARY SOURCES
           2.2.1 KEY DATA FROM SECONDARY SOURCES
    2.3 PRIMARY DATA
           2.3.1 PRIMARY SOURCES
           2.3.2 BREAKDOWN OF PRIMARY INTERVIEWS
           FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION
                    2.3.2.1 Key industry insights
    2.4 MARKET SIZE ESTIMATION
           FIGURE 1 BOTTOM-UP APPROACH
           FIGURE 2 TOP-DOWN APPROACH
           FIGURE 3 ESTIMATION OF THE AI IN GENOMICS MARKET SIZE THROUGH THE ADOPTION-BASED APPROACH
           TABLE 1 FACTOR ANALYSIS
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 4 DATA TRIANGULATION METHODOLOGY
    2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 37)
           FIGURE 5 AI IN GENOMICS MARKET, BY OFFERING, 2020 VS. 2025 (USD MILLION)
           FIGURE 6 AI IN GENOMICS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
           FIGURE 7 AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2020 VS. 2025 (USD MILLION)
           FIGURE 8 AI IN GENOMICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
           FIGURE 9 AI IN GENOMICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
           FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE AI IN GENOMICS MARKET

4 PREMIUM INSIGHTS (Page No. - 41)
    4.1 AI IN GENOMICS: MARKET OVERVIEW
           FIGURE 11 INCREASING PUBLIC AND PRIVATE INVESTMENTS IN AI IN GENOMICS AND ADOPTION OF AI SOLUTIONS FOR PRECISION MEDICINE ARE DRIVING MARKET GROWTH
    4.2 AI IN GENOMICS MARKET, BY END USER
           FIGURE 12 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
    4.3 NORTH AMERICA: AI IN GENOMICS MARKET, BY TECHNOLOGY & COUNTRY (2019)
           FIGURE 13 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
    4.4 GEOGRAPHICAL SNAPSHOT OF THE AI IN GENOMICS MARKET
           FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 44)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Need to control the time and costs of drug development and discovery
                    5.2.1.2 Increasing investments in AI in genomics
                    5.2.1.3 Rising adoption of AI in precision medicine
                    5.2.1.4 Growing genomic datasets
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Focus on developing human-aware AI systems
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of curated genomic data
                    5.2.4.2 Data privacy concerns
    5.3 IMPACT OF COVID-19 ON THE AI IN GENOMICS MARKET
           FIGURE 15 IMPACT OF COVID-19 ON THE AI IN GENOMICS MARKET
    5.4 ECOSYSTEM
           FIGURE 16 AI IN GENOMICS MARKET: ECOSYSTEM

6 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING (Page No. - 51)
    6.1 INTRODUCTION
           TABLE 2 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
    6.2 SOFTWARE
           6.2.1 BENEFITS OFFERED BY SOFTWARE & STRONG DEMAND AMONG END USERS ARE DRIVING MARKET GROWTH
           TABLE 3 AI IN GENOMICS MARKET FOR SOFTWARE, BY REGION, 2018�2025 (USD MILLION)
           TABLE 4 NORTH AMERICA: AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 5 EUROPE: AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY, 2018�2025 (USD MILLION)
    6.3 SERVICES
           6.3.1 SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
           TABLE 6 AI IN GENOMICS MARKET FOR SERVICES, BY REGION, 2018�2025 (USD MILLION)
           TABLE 7 NORTH AMERICA: AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 8 EUROPE: AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2018�2025 (USD MILLION)

7 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY (Page No. - 56)
    7.1 INTRODUCTION
           TABLE 9 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
    7.2 MACHINE LEARNING
           TABLE 10 AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 11 AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 12 NORTH AMERICA: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 13 EUROPE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           7.2.1 DEEP LEARNING
                    7.2.1.1 Deep learning is the fastest-growing and largest subsegment of machine learning
           TABLE 14 AI IN GENOMICS MARKET FOR DEEP LEARNING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 15 NORTH AMERICA: AI IN GENOMICS MARKET FOR DEEP LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 16 EUROPE: AI IN GENOMICS MARKET FOR DEEP LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           7.2.2 SUPERVISED LEARNING
                    7.2.2.1 Supervised learning can help create predictive models
           TABLE 17 AI IN GENOMICS MARKET FOR SUPERVISED LEARNING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 18 NORTH AMERICA: AI IN GENOMICS MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 19 EUROPE: AI IN GENOMICS MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           7.2.3 REINFORCEMENT LEARNING
                    7.2.3.1 APAC to show the highest growth in the reinforcement learning market
           TABLE 20 AI IN GENOMICS MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 21 NORTH AMERICA: AI IN GENOMICS MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 22 EUROPE: AI IN GENOMICS MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           7.2.4 UNSUPERVISED LEARNING
                    7.2.4.1 Unsupervised learning algorithms allow for complex processing tasks, exceeding the capabilities of supervised systems
           TABLE 23 AI IN GENOMICS MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 24 NORTH AMERICA: AI IN GENOMICS MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 25 EUROPE: AI IN GENOMICS MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2018�2025 (USD MILLION)
           7.2.5 OTHER MACHINE LEARNING TECHNOLOGIES
           TABLE 26 AI IN GENOMICS MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY REGION, 2018�2025 (USD MILLION)
           TABLE 27 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 28 EUROPE: AI IN GENOMICS MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2018�2025 (USD MILLION)
    7.3 OTHER TECHNOLOGIES
           TABLE 29 AI IN GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018�2025 (USD MILLION)
           TABLE 30 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 31 EUROPE: AI IN GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018�2025 (USD MILLION)

8 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY (Page No. - 67)
    8.1 INTRODUCTION
           TABLE 32 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
    8.2 GENOME SEQUENCING
           8.2.1 GENOME SEQUENCING HOLDS THE LARGEST SHARE OF THE MARKET, BY FUNCTIONALITY
           TABLE 33 AI IN GENOMICS MARKET FOR GENOME SEQUENCING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 34 NORTH AMERICA: AI IN GENOMICS MARKET FOR GENOME SEQUENCING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 35 EUROPE: AI IN GENOMICS MARKET FOR GENOME SEQUENCING, BY COUNTRY, 2018�2025 (USD MILLION)
    8.3 GENE EDITING
           8.3.1 GROWING IMPLEMENTATION OF MACHINE LEARNING IN GENE EDITING MAY HELP REDUCE TIME AND COSTS
           TABLE 36 AI IN GENOMICS MARKET FOR GENE EDITING, BY REGION, 2018�2025 (USD MILLION)
           TABLE 37 NORTH AMERICA: AI IN GENOMICS MARKET FOR GENE EDITING, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 38 EUROPE: AI IN GENOMICS MARKET FOR GENE EDITING, BY COUNTRY, 2018�2025 (USD MILLION)
    8.4 CLINICAL WORKFLOWS
           8.4.1 MACHINE LEARNING CAN HELP INCREASE THE EFFICIENCY OF THE CLINICAL WORKFLOW
           TABLE 39 AI IN GENOMICS MARKET FOR CLINICAL WORKFLOW, BY REGION, 2018�2025 (USD MILLION)
           TABLE 40 NORTH AMERICA: AI IN GENOMICS MARKET FOR CLINICAL WORKFLOW, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 41 EUROPE: AI IN GENOMICS MARKET FOR CLINICAL WORKFLOW, BY COUNTRY, 2018�2025 (USD MILLION)
    8.5 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE
           8.5.1 AI IN GENOMICS CAN PREDICT OUTCOMES AND THE RISKS ASSOCIATED IN CURING GENETIC DISEASES, BASED ON THE AVAILABLE DATA
           TABLE 42 AI IN GENOMICS MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2018�2025 (USD MILLION)
           TABLE 43 NORTH AMERICA: AI IN GENOMICS MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 44 EUROPE: AI IN GENOMICS MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2018�2025 (USD MILLION)

9 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION (Page No. - 74)
    9.1 INTRODUCTION
           TABLE 45 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
    9.2 DIAGNOSTICS
           9.2.1 DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE AI IN GENOMICS MARKET
           TABLE 46 AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2018�2025 (USD MILLION)
           TABLE 47 NORTH AMERICA: AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 48 EUROPE: AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)
    9.3 DRUG DISCOVERY & DEVELOPMENT
           9.3.1 GROWING APPLICATION OF AI IN GENOMICS IN DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET GROWTH
           TABLE 49 INDICATIVE LIST OF DEVELOPMENTS
           TABLE 50 AI IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018�2025 (USD MILLION)
           TABLE 51 NORTH AMERICA: AI IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 52 EUROPE: AI IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018�2025 (USD MILLION)
    9.4 PRECISION MEDICINE
           9.4.1 PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS
           TABLE 53 INDICATIVE LIST OF DEVELOPMENTS FOR PRECISION MEDICINE APPLICATION
           TABLE 54 AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY REGION, 2018�2025 (USD MILLION)
           TABLE 55 NORTH AMERICA: AI IN GENOMICS MARKET FOR PRECISION MEDICINE,BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 56 EUROPE: AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY, 2018�2025 (USD MILLION)
    9.5 AGRICULTURE & ANIMAL RESEARCH
           9.5.1 AI IN GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK
           TABLE 57 AI IN GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018�2025 (USD MILLION)
           TABLE 58 NORTH AMERICA: AI IN GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 59 EUROPE: AI IN GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018�2025 (USD MILLION)
    9.6 OTHER APPLICATIONS
           TABLE 60 AI IN GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018�2025 (USD MILLION)
           TABLE 61 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 62 EUROPE: AI IN GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018�2025 (USD MILLION)

10 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END USER (Page No. - 84)
     10.1 INTRODUCTION
           TABLE 63 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
     10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
             10.2.1 RISING DEMAND FOR SOLUTIONS TO CUT TIME AND COSTS OF DRUG DEVELOPMENT HAVE DRAWN END-USER ATTENTION TO AI IN GENOMICS
           TABLE 64 INDICATIVE LIST OF DEVELOPMENTS
           TABLE 65 AI IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018�2025 (USD MILLION)
           TABLE 66 NORTH AMERICA: AI IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 67 EUROPE: AI IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018�2025 (USD MILLION)
     10.3 RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS
             10.3.1 RISING RESEARCH ACTIVITY TO DRIVE THE USAGE OF AI IN GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES
           TABLE 68 INDICATIVE LIST OF RESEARCH COLLABORATIONS
           TABLE 69 AI IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY REGION, 2018�2025 (USD MILLION)
           TABLE 70 NORTH AMERICA: AI IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 71 EUROPE: AI IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2018�2025 (USD MILLION)
     10.4 HEALTHCARE PROVIDERS
             10.4.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS
           TABLE 72 AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2018�2025 (USD MILLION)
           TABLE 73 NORTH AMERICA: AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 74 EUROPE: AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2018�2025 (USD MILLION)
     10.5 OTHER END USERS
           TABLE 75 AI IN GENOMICS MARKET FOR OTHER END USERS, BY REGION, 2018�2025 (USD MILLION)
           TABLE 76 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 77 EUROPE: AI IN GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2018�2025 (USD MILLION)

11 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY REGION (Page No. - 92)
     11.1 INTRODUCTION
           TABLE 78 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY REGION, 2018�2025 (USD MILLION)
     11.2 NORTH AMERICA
           FIGURE 17 NORTH AMERICA: AI IN GENOMICS MARKET SNAPSHOT
           TABLE 79 NORTH AMERICA: AI IN GENOMICS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 80 NORTH AMERICA: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 81 NORTH AMERICA: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 82 NORTH AMERICA: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 83 NORTH AMERICA: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 84 NORTH AMERICA: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 85 NORTH AMERICA: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
             11.2.1 US
                        11.2.1.1 The US dominates the North American AI in genomics market
           TABLE 86 US: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS
           TABLE 87 US: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 88 US: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 89 US: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 90 US: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 91 US: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 92 US: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Increasing research in genomics to drive market growth
           TABLE 93 CANADA: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 94 CANADA: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 95 CANADA: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 96 CANADA: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 97 CANADA: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 98 CANADA: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
     11.3 EUROPE
           TABLE 99 EUROPE: AI IN GENOMICS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
           TABLE 100 EUROPE: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 101 EUROPE: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 102 EUROPE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 103 EUROPE: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 104 EUROPE: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 105 EUROPE: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
             11.3.1 UK
                        11.3.1.1 UK to register the highest CAGR in the European market during the forecast period
           TABLE 106 UK: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 107 UK: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 108 UK: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 109 UK: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 110 UK: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 111 UK: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Availability of funding for AI initiatives to boost the market growth in Germany
           TABLE 112 GERMANY: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 113 GERMANY: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 114 GERMANY: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 115 GERMANY: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 116 GERMANY: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 117 GERMANY: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Increasing government investments in genomics to boost the growth of the French market
           TABLE 118 FRANCE: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 119 FRANCE: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 120 FRANCE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 121 FRANCE: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 122 FRANCE: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 123 FRANCE: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
             11.3.4 ROE
           TABLE 124 ROE: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 125 ROE: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 126 ROE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 127 ROE: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 128 ROE: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 129 ROE: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
     11.4 ASIA PACIFIC
             11.4.1 EFFORTS TO DEVELOP IT INFRASTRUCTURE WILL DRIVE THE MARKET FOR AI IN THE APAC
           FIGURE 18 ASIA PACIFIC: AI IN GENOMICS MARKET SNAPSHOT
           TABLE 130 ASIA PACIFIC: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 131 ASIA PACIFIC: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 132 ASIA PACIFIC: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 133 ASIA PACIFIC: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 134 ASIA PACIFIC: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 135 ASIA PACIFIC: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)
     11.5 ROW
           TABLE 136 ROW: AI IN GENOMICS MARKET, BY OFFERING, 2018�2025 (USD MILLION)
           TABLE 137 ROW: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)
           TABLE 138 ROW: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018�2025 (USD MILLION)
           TABLE 139 ROW: AI IN GENOMICS MARKET, BY FUNCTIONALITY, 2018�2025 (USD MILLION)
           TABLE 140 ROW: AI IN GENOMICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
           TABLE 141 ROW: AI IN GENOMICS MARKET, BY END USER, 2018�2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 122)
     12.1 OVERVIEW
           FIGURE 19 KEY DEVELOPMENTS IN THE AI IN GENOMICS MARKET (2018�2020)
     12.2 AI IN GENOMICS MARKET: RANKING ANALYSIS (2019)
           FIGURE 20 MARKET RANKING ANALYSIS, 2019
     12.3 COMPETITIVE SCENARIO (2018�2020)
             12.3.1 KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2018�2020)
             12.3.2 KEY PRODUCT LAUNCHES (2018�2020)
             12.3.3 KEY EXPANSIONS (2018�2020)
             12.3.4 KEY ACQUISITIONS (2018�2020)
     12.4 COMPETITIVE LEADERSHIP MAPPING
     12.5 VENDOR INCLUSION CRITERIA
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 EMERGING COMPANIES
           FIGURE 21 AI IN GENOMICS: COMPETITIVE LEADERSHIP MAPPING, 2019

13 COMPANY PROFILES (Page No. - 127)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     13.1 IBM
           FIGURE 22 IBM: COMPANY SNAPSHOT (2019)
     13.2 NVIDIA
           FIGURE 23 NVIDIA: COMPANY SNAPSHOT (2019)
     13.3 MICROSOFT CORPORATION
           FIGURE 24 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2020)
     13.4 DEEP GENOMICS
     13.5 BENEVOLENTAI
     13.6 FABRIC GENOMICS
     13.7 VERGE GENOMICS
     13.8 FREENOME HOLDINGS
     13.9 MOLECULARMATCH
     13.10 CAMBRIDGE CANCER GENOMICS
     13.11 SOPHIA GENETICS
     13.12 DATA4CURE
     13.13 PRECISIONLIFE
     13.14 GENOOX
     13.15 LIFEBIT
     13.16 DIPLOID
     13.17 FDNA
     13.18 DNANEXUS
     13.19 EMPIRIC LOGIC
     13.20 ENGINE BIOSCIENCES
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 149)
     14.1 DISCUSSION GUIDE
     14.2 AVAILABLE CUSTOMIZATIONS
     14.3 RELATED REPORTS
     14.4 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the blood collection devices market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as WHO, PhRMA, AAAI and OECD. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global AI in genomics market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global AI in genomics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, pharmaceutical and biotechnology, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions�North America, Europe, the Asia Pacific, and Rest of the World. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Artificial Intelligence In Genomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the AI in genomics market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the global AI in genomics market and other adjucent submarkets. The research methodology and the market numbers were then validated from primaries.

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the AI in genomics market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the AI in genomics market

Report Objectives

To define, describe, segment, and forecast the AI in genomics market based on offering, technology, functionality, application, end user and region
To provide detailed information about the factors influencing market growth, such as drivers, opportunities, restraints and challenges
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall in AI in genomics market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific (APAC), and RoW
To profile the key players in the global AI in genomics market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments, such as product launches, expansions, acquisition and partnerships in the AI in genomics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Company information